Table of Contents Executive Summary 1 Industry Overview of Infectious Vaccines 1.1 Definition of Infectious Vaccines 1.2 Infectious Vaccines Segment by Type 1.2.1 Global Infectious Vaccines Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Preventive vaccine 1.2.3 Therapeutic vaccine 1.3 Infectious Vaccines Segment by Applications 1.3.1 Global Infectious Vaccines Consumption Comparison by Applications (2014-2025) 1.3.2 Adults 1.3.3 Pediatrics 1.4 Global Infectious Vaccines Overall Market 1.4.1 Global Infectious Vaccines Revenue (2014-2025) 1.4.2 Global Infectious Vaccines Production (2014-2025) 1.4.3 North America Infectious Vaccines Status and Prospect (2014-2025) 1.4.4 Europe Infectious Vaccines Status and Prospect (2014-2025) 1.4.5 China Infectious Vaccines Status and Prospect (2014-2025) 1.4.6 Japan Infectious Vaccines Status and Prospect (2014-2025) 1.4.7 Southeast Asia Infectious Vaccines Status and Prospect (2014-2025) 1.4.8 India Infectious Vaccines Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Infectious Vaccines 2.3 Manufacturing Process Analysis of Infectious Vaccines 2.4 Industry Chain Structure of Infectious Vaccines 3 Development and Manufacturing Plants Analysis of Infectious Vaccines 3.1 Capacity and Commercial Production Date 3.2 Global Infectious Vaccines Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Infectious Vaccines 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Infectious Vaccines Production and Capacity Analysis 4.2 Infectious Vaccines Revenue Analysis 4.3 Infectious Vaccines Price Analysis 4.4 Market Concentration Degree 5 Infectious Vaccines Regional Market Analysis 5.1 Infectious Vaccines Production by Regions 5.1.1 Global Infectious Vaccines Production by Regions 5.1.2 Global Infectious Vaccines Revenue by Regions 5.2 Infectious Vaccines Consumption by Regions 5.3 North America Infectious Vaccines Market Analysis 5.3.1 North America Infectious Vaccines Production 5.3.2 North America Infectious Vaccines Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Infectious Vaccines Import and Export 5.4 Europe Infectious Vaccines Market Analysis 5.4.1 Europe Infectious Vaccines Production 5.4.2 Europe Infectious Vaccines Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Infectious Vaccines Import and Export 5.5 China Infectious Vaccines Market Analysis 5.5.1 China Infectious Vaccines Production 5.5.2 China Infectious Vaccines Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Infectious Vaccines Import and Export 5.6 Japan Infectious Vaccines Market Analysis 5.6.1 Japan Infectious Vaccines Production 5.6.2 Japan Infectious Vaccines Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Infectious Vaccines Import and Export 5.7 Southeast Asia Infectious Vaccines Market Analysis 5.7.1 Southeast Asia Infectious Vaccines Production 5.7.2 Southeast Asia Infectious Vaccines Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Infectious Vaccines Import and Export 5.8 India Infectious Vaccines Market Analysis 5.8.1 India Infectious Vaccines Production 5.8.2 India Infectious Vaccines Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Infectious Vaccines Import and Export 6 Infectious Vaccines Segment Market Analysis (by Type) 6.1 Global Infectious Vaccines Production by Type 6.2 Global Infectious Vaccines Revenue by Type 6.3 Infectious Vaccines Price by Type 7 Infectious Vaccines Segment Market Analysis (by Application) 7.1 Global Infectious Vaccines Consumption by Application 7.2 Global Infectious Vaccines Consumption Market Share by Application (2014-2019) 8 Infectious Vaccines Major Manufacturers Analysis 8.1 CSL Limited (Australia) 8.1.1 CSL Limited (Australia) Infectious Vaccines Production Sites and Area Served 8.1.2 CSL Limited (Australia) Product Introduction, Application and Specification 8.1.3 CSL Limited (Australia) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Bavarian Nordic (Denmark) 8.2.1 Bavarian Nordic (Denmark) Infectious Vaccines Production Sites and Area Served 8.2.2 Bavarian Nordic (Denmark) Product Introduction, Application and Specification 8.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 GlaxoSmithKline plc. (U.K.) 8.3.1 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Sites and Area Served 8.3.2 GlaxoSmithKline plc. (U.K.) Product Introduction, Application and Specification 8.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Emergent Bio Solutions Inc. (U.S.) 8.4.1 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Sites and Area Served 8.4.2 Emergent Bio Solutions Inc. (U.S.) Product Introduction, Application and Specification 8.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 MedImmune LLC (U.S.) 8.5.1 MedImmune LLC (U.S.) Infectious Vaccines Production Sites and Area Served 8.5.2 MedImmune LLC (U.S.) Product Introduction, Application and Specification 8.5.3 MedImmune LLC (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Johnson and Johnson (U.S.) 8.6.1 Johnson and Johnson (U.S.) Infectious Vaccines Production Sites and Area Served 8.6.2 Johnson and Johnson (U.S.) Product Introduction, Application and Specification 8.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Novartis AG (Switzerland) 8.7.1 Novartis AG (Switzerland) Infectious Vaccines Production Sites and Area Served 8.7.2 Novartis AG (Switzerland) Product Introduction, Application and Specification 8.7.3 Novartis AG (Switzerland) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Merck and Company (U.S.) 8.8.1 Merck and Company (U.S.) Infectious Vaccines Production Sites and Area Served 8.8.2 Merck and Company (U.S.) Product Introduction, Application and Specification 8.8.3 Merck and Company (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Sanofi Pasteur (France) 8.9.1 Sanofi Pasteur (France) Infectious Vaccines Production Sites and Area Served 8.9.2 Sanofi Pasteur (France) Product Introduction, Application and Specification 8.9.3 Sanofi Pasteur (France) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Pfizer Inc. (U.S.) 8.10.1 Pfizer Inc. (U.S.) Infectious Vaccines Production Sites and Area Served 8.10.2 Pfizer Inc. (U.S.) Product Introduction, Application and Specification 8.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Infectious Vaccines Market 9.1 Global Infectious Vaccines Market Trend Analysis 9.1.1 Global Infectious Vaccines Market Size (Volume and Value) Forecast 2019-2025 9.2 Infectious Vaccines Regional Market Trend 9.2.1 North America Infectious Vaccines Forecast 2019-2025 9.2.2 Europe Infectious Vaccines Forecast 2019-2025 9.2.3 China Infectious Vaccines Forecast 2019-2025 9.2.4 Japan Infectious Vaccines Forecast 2019-2025 9.2.5 Southeast Asia Infectious Vaccines Forecast 2019-2025 9.2.6 India Infectious Vaccines Forecast 2019-2025 9.3 Infectious Vaccines Market Trend (Product Type) 9.4 Infectious Vaccines Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Infectious Vaccines Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Infectious Vaccines Table Global Infectious Vaccines Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Infectious Vaccines Production Market Share by Types in 2018 Figure Preventive vaccine Product Picture Figure Therapeutic vaccine Product Picture Table Global Infectious Vaccines Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Infectious Vaccines Consumption Market Share by Applications in 2018 Figure Adults Figure Pediatrics Figure Global Infectious Vaccines Revenue (Million USD) (2014-2025) Figure Global Infectious Vaccines Production (K Units) (2014-2025) Figure North America Infectious Vaccines Market Size (Million USD) (2014-2025) Figure Europe Infectious Vaccines Market Size (Million USD) (2014-2025) Figure China Infectious Vaccines Market Size (Million USD) (2014-2025) Figure Japan Infectious Vaccines Market Size (Million USD) (2014-2025) Figure Southeast Asia Infectious Vaccines Market Size (Million USD) (2014-2025) Figure India Infectious Vaccines Market Size (Million USD) (2014-2025) Table Infectious Vaccines Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Infectious Vaccines in 2018 Figure Manufacturing Process Analysis of Infectious Vaccines Figure Industry Chain Structure of Infectious Vaccines Table Capacity and Commercial Production Date of Key Manufacturers Table Global Infectious Vaccines Manufacturing Plants Distribution Table Infectious Vaccines Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Infectious Vaccines Capacity (K Units) of Major Manufacturers (2014-2019) Table Infectious Vaccines Production (K Units) of Major Manufacturers (2014-2019) Table Infectious Vaccines Production Market Share of Major Manufacturers (2014-2019) Figure Infectious Vaccines Production Share by Manufacturers in 2018 Table Infectious Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019) Table Infectious Vaccines Revenue Market Share of Major Manufacturers (2014-2019) Figure Infectious Vaccines Revenue Share by Manufacturers in 2018 Table Infectious Vaccines Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Infectious Vaccines Production by Regions 2014-2019 (K Units) Table Global Infectious Vaccines Production Market Share by Regions 2014-2019 Figure Global Infectious Vaccines Production Market Share by Regions in 2018 Table Global Infectious Vaccines Revenue by Regions 2014-2019 (Million USD) Table Global Infectious Vaccines Revenue Market Share by Regions 2014-2019 Figure Global Infectious Vaccines Revenue Market Share by Regions in 2018 Table Global Infectious Vaccines Consumption by Regions 2014-2019 (K Units) Table Global Infectious Vaccines Consumption Market Share by Regions 2014-2019 Figure North America Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure North America Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table North America Infectious Vaccines Production, Consumption Import and Export (K Units) Figure Europe Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure Europe Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Europe Infectious Vaccines Production, Consumption Import and Export (K Units) Figure China Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure China Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table China Infectious Vaccines Production, Consumption Import and Export (K Units) Figure Japan Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure Japan Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Japan Infectious Vaccines Production, Consumption Import and Export (K Units) Figure Southeast Asia Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Infectious Vaccines Production, Consumption Import and Export (K Units) Figure India Infectious Vaccines Production Growth Rate 2014-2019 (K Units) Figure India Infectious Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table India Infectious Vaccines Production, Consumption Import and Export (K Units) Figure Global Consumption Infectious Vaccines Market Share by Application (2014-2019) Figure Global Value (Consumption) Infectious Vaccines Market Share by Application (2014-2019) Table CSL Limited (Australia) Infectious Vaccines Production Sites and Area Served Table CSL Limited (Australia) Infectious Vaccines Product Introduction, Application and Specification Table CSL Limited (Australia) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table CSL Limited (Australia) Infectious Vaccines Production Growth Rate (2014-2019) Table CSL Limited (Australia) Infectious Vaccines Production Market Share (2014-2019) Figure CSL Limited (Australia) Infectious Vaccines Revenue Market Share (2014-2019) Table CSL Limited (Australia) Infectious Vaccines Main Business and Markets Served Table Bavarian Nordic (Denmark) Infectious Vaccines Production Sites and Area Served Table Bavarian Nordic (Denmark) Infectious Vaccines Product Introduction, Application and Specification Table Bavarian Nordic (Denmark) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bavarian Nordic (Denmark) Infectious Vaccines Production Growth Rate (2014-2019) Table Bavarian Nordic (Denmark) Infectious Vaccines Production Market Share (2014-2019) Figure Bavarian Nordic (Denmark) Infectious Vaccines Revenue Market Share (2014-2019) Table Bavarian Nordic (Denmark) Infectious Vaccines Main Business and Markets Served Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Sites and Area Served Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Introduction, Application and Specification Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Growth Rate (2014-2019) Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Market Share (2014-2019) Figure GlaxoSmithKline plc. (U.K.) Infectious Vaccines Revenue Market Share (2014-2019) Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Main Business and Markets Served Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Sites and Area Served Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Introduction, Application and Specification Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Growth Rate (2014-2019) Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Market Share (2014-2019) Figure Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Revenue Market Share (2014-2019) Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Main Business and Markets Served Table MedImmune LLC (U.S.) Infectious Vaccines Production Sites and Area Served Table MedImmune LLC (U.S.) Infectious Vaccines Product Introduction, Application and Specification Table MedImmune LLC (U.S.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table MedImmune LLC (U.S.) Infectious Vaccines Production Growth Rate (2014-2019) Table MedImmune LLC (U.S.) Infectious Vaccines Production Market Share (2014-2019) Figure MedImmune LLC (U.S.) Infectious Vaccines Revenue Market Share (2014-2019) Table MedImmune LLC (U.S.) Infectious Vaccines Main Business and Markets Served Table Johnson and Johnson (U.S.) Infectious Vaccines Production Sites and Area Served Table Johnson and Johnson (U.S.) Infectious Vaccines Product Introduction, Application and Specification Table Johnson and Johnson (U.S.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson and Johnson (U.S.) Infectious Vaccines Production Growth Rate (2014-2019) Table Johnson and Johnson (U.S.) Infectious Vaccines Production Market Share (2014-2019) Figure Johnson and Johnson (U.S.) Infectious Vaccines Revenue Market Share (2014-2019) Table Johnson and Johnson (U.S.) Infectious Vaccines Main Business and Markets Served Table Novartis AG (Switzerland) Infectious Vaccines Production Sites and Area Served Table Novartis AG (Switzerland) Infectious Vaccines Product Introduction, Application and Specification Table Novartis AG (Switzerland) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG (Switzerland) Infectious Vaccines Production Growth Rate (2014-2019) Table Novartis AG (Switzerland) Infectious Vaccines Production Market Share (2014-2019) Figure Novartis AG (Switzerland) Infectious Vaccines Revenue Market Share (2014-2019) Table Novartis AG (Switzerland) Infectious Vaccines Main Business and Markets Served Table Merck and Company (U.S.) Infectious Vaccines Production Sites and Area Served Table Merck and Company (U.S.) Infectious Vaccines Product Introduction, Application and Specification Table Merck and Company (U.S.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck and Company (U.S.) Infectious Vaccines Production Growth Rate (2014-2019) Table Merck and Company (U.S.) Infectious Vaccines Production Market Share (2014-2019) Figure Merck and Company (U.S.) Infectious Vaccines Revenue Market Share (2014-2019) Table Merck and Company (U.S.) Infectious Vaccines Main Business and Markets Served Table Sanofi Pasteur (France) Infectious Vaccines Production Sites and Area Served Table Sanofi Pasteur (France) Infectious Vaccines Product Introduction, Application and Specification Table Sanofi Pasteur (France) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Pasteur (France) Infectious Vaccines Production Growth Rate (2014-2019) Table Sanofi Pasteur (France) Infectious Vaccines Production Market Share (2014-2019) Figure Sanofi Pasteur (France) Infectious Vaccines Revenue Market Share (2014-2019) Table Sanofi Pasteur (France) Infectious Vaccines Main Business and Markets Served Table Pfizer Inc. (U.S.) Infectious Vaccines Production Sites and Area Served Table Pfizer Inc. (U.S.) Infectious Vaccines Product Introduction, Application and Specification Table Pfizer Inc. (U.S.) Infectious Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc. (U.S.) Infectious Vaccines Production Growth Rate (2014-2019) Table Pfizer Inc. (U.S.) Infectious Vaccines Production Market Share (2014-2019) Figure Pfizer Inc. (U.S.) Infectious Vaccines Revenue Market Share (2014-2019) Table Pfizer Inc. (U.S.) Infectious Vaccines Main Business and Markets Served Figure Global Infectious Vaccines Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Infectious Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Infectious Vaccines Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure China Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Infectious Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure India Infectious Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Infectious Vaccines by Type (2019-2025) Table Global Consumption (K Units) of Infectious Vaccines by Application (2019-2025) Table Infectious Vaccines Distributors List Table Infectious Vaccines Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

CSL Limited (Australia) Bavarian Nordic (Denmark) GlaxoSmithKline plc. (U.K.) Emergent Bio Solutions Inc. (U.S.) MedImmune LLC (U.S.) Johnson and Johnson (U.S.) Novartis AG (Switzerland) Merck and Company (U.S.) Sanofi Pasteur (France) Pfizer Inc. (U.S.)